PARP-inhibitors for BRCA1/2-related advanced HER2-negative breast cancer: A meta-analysis and GRADE recommendations by the Italian Association of Medical Oncology

Federica Miglietta, Stefania Gori, Pierfrancesco Franco et al.|The Breast|2022

Cited by 16